Cargando…
Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by pregnancy morbidity or thrombosis and persistent antiphospholipid antibodies (aPL) that bind to the endothelium and induce endothelial activation, which is evidenced by the expression of adhesion molecules and the production...
Autores principales: | Velásquez, Manuela, Peláez, Luisa F., Rojas, Mauricio, Narváez-Sánchez, Raúl, Velásquez, Jesús A., Escudero, Carlos, San Martín, Sebastián, Cadavid, Ángela P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675389/ https://www.ncbi.nlm.nih.gov/pubmed/34925061 http://dx.doi.org/10.3389/fphys.2021.764702 |
Ejemplares similares
-
Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations
por: Velásquez, Manuela, et al.
Publicado: (2018) -
Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy
por: Rodríguez, Carlos M., et al.
Publicado: (2021) -
Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022) -
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
por: Nath, Karthik, et al.
Publicado: (2018) -
Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
por: Stanisavljevic, Natasa, et al.
Publicado: (2022)